Back9 Meters Biopharma Overview

9 Meters Biopharma Income Tax

Track 9 Meters Biopharma's income tax ($3.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Income Tax

$1.83M
14758.56% YoY

As of Mar 2023

Annual Income Tax (TTM)

$3.52M
61800.95% YoY

Trailing 12 months ending Mar 2023

Average Income Tax (Comparison Companies)

Loading

Income Tax History

Loading

Income Tax Comparison

Loading

Annual Income Tax Growth Rate (%)

Loading...

Annual Income Tax Growth (Absolute)

Loading...

9 Meters Biopharma (NMTR) FAQ

9 Meters Biopharma posts a income tax of $3.5M as of March 2023. That compares with $5.7K in the prior-year period — up 61801.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, 9 Meters Biopharma's income tax was $5.7K. The latest reading is $3.5M — a 61801.0% year-over-year increase (period ending March 2023). Use the history and growth charts on this page for a longer lookback.

Income Tax is one piece of 9 Meters Biopharma's financial statement story. At $3.5M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NMTR's income tax usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; 9 Meters Biopharma's other metric pages and overview cover the third.

Judging 9 Meters Biopharma against Technology peers is usually better than using a market-wide rule of thumb. Business models inside Technology are more comparable, which makes gaps in income tax easier to interpret. Start with $3.5M here, then scan peer and history charts to see if the gap is persistent.